Simultaneous liquid-chromatographic determination of some bronchodilators, anticonvulsants, chloramphenicol, and hypnotic agents, with Chromosorb P columns used for sample preparation.
We describe a simple liquid-chromatographic system for simultaneously measuring bronchodilators, anticonvulsants, hypnotics, and chloramphenicol. Use in therapeutic drug monitoring includes determination of theophylline, caffeine, chloramphenicol, ethosuximide, primidone, phenobarbital, phenacemide, phenytoin, mephenytoin, nirvanol, and carbamazepine and its bioactive metabolites within 13 min. In the "toxicology mode" theophylline, caffeine, barbital, butabarbital, pentobarbital, amobarbital, secobarbital, primidone, phenobarbital, methylprylon, glutethimide, methaqualone, phenytoin, mephenytoin, nirvanol, and carbamazepine and its bioactive metabolites are resolved within 17 min. A reversed-phase C8 column (5-microns particles) is used, with acetonitrile/water (20/80 by vol) as mobile phase. The drugs are extracted from 50 microL of serum with use of a Chromosorb P microcolumn and chloroform/isopropanol (6/1 by vol). The drugs are quantified by absorbance at 208 nm, with tolylphenobarbital as internal standard. Lower limits of detection varied from 0.05 to 0.1 mg/L, analytical recovery from 94% to 106%; CVs were less than 5.6% within run, less than 6.9% between runs.
Clinical Laboratory, Medical Academy, Sofia, Bulgaria.
D A
DA
Svinarov
D C
DC
Dotchev
D000927:Anticonvulsants / Q000097:blood*; D001993:Bronchodilator Agents / Q000097:blood*; D002701:Chloramphenicol / Q000097:blood*; D002853:Chromatography, Liquid / Q000379:methods; D007692:Diatomaceous Earth; D006801:Humans; D006993:Hypnotics and Sedatives / Q000097:blood*
D000927:Anticonvulsants; D001993:Bronchodilator Agents; D006993:Hypnotics and Sedatives; D007692:Diatomaceous Earth; D002701:Chloramphenicol